Small-Cap Momentum Watch: Upcoming Catalysts for October 12–16
10/10/20266 min read
From operational updates to conference participation, we’ve highlighted the small-cap events that could drive attention this week.
--
Companies Participating at the 2026 Maxim Growth Summit
The 2026 Maxim Growth Summit will take place October 13–14, 2026, at the Hard Rock Hotel in New York City. The invitation-only event will bring together entrepreneurs, corporate leaders, investors, and innovators across multiple industries for keynote presentations, panel discussions, curated one-on-one meetings, networking, and strategic discussions focused on growth opportunities, capital formation, business development, and emerging market themes.
SRFM, FLNA, BRAI, DVLT, GANX, DRK, IMNN, GOAI, AREC, APRE, DFDV, MNOV, UPXI, DWTX, INMB, AENT, RDZN, GAME, AIDX, VTIX, LABT, SBC, ANGX, MBAI, MRLN, CAST, GYGY, MBRX, APRE
Companies Participating at the 2026 AUSA Annual Meeting & Exposition
The 2026 AUSA Annual Meeting & Exposition will take place October 12–14, 2026, at the Walter E. Washington Convention Center in Washington, D.C. Hosted by the Association of the United States Army, the event is a major land-power exposition and professional-development forum, bringing together defense companies, military leaders, government officials, industry participants, and investors for product demonstrations, exhibits, senior-leader engagements, and discussions focused on defense technology, modernization, readiness, and emerging military capabilities.
PRZO, KOPN, FBDT, MOB, MTEK, MVIS, CHGA
Companies Participating at The ThinkEquity Conference 2026
The ThinkEquity Conference 2026 will take place on October 15, 2026. Hosted by ThinkEquity, the annual event brings together emerging-growth public and private companies, institutional investors, and industry professionals for company presentations, investor meetings, networking, and discussions focused on growth strategies, capital formation, business development, and investment opportunities across a range of sectors.
IMNN, AENT, LABT, MBAI, GAME, RGNT, SIDU, ROLR, FFR, BMR, LTRN, ATCH, OPTH, STEX, CFND, RDZN, TRUG, SBC
Other Companies with Material Events This Week
● ATHE – CEO David Stamler will present at the Canaccord Genuity Drug and Device Conference in Australia on October 12, 2026 at 3:50 p.m. AEST and will also participate in investor roundtable discussions.
● AREC – Management will participate in The Battery Show North America in Detroit from October 12–15, 2026. Executive Director Mark LaVerghetta and CFO Kirk Taylor will represent American Resources and ReElement in meetings with institutional investors and other investment-community participants.
● BEEM – Will present developments in advanced battery technologies at The Battery Show North America in Detroit from October 12–15, 2026. Topics will include battery energy-storage systems for high-power applications such as AI data centers and electric aviation, including technologies designed to manage extreme power fluctuations and high-rate cycling.
● QS – Will display its PowerBlock design at the 2026 OCP Global Summit in San Jose from October 12–15, 2026 at partner Megmeet’s Booth C19. The company also announced that it has joined the Open Compute Project as a member as it targets high-density power infrastructure for AI data centers.
● ALEC – Will host a virtual pipeline webinar on October 13, 2026 at 8:00 a.m. PT focused on its wholly owned ABC blood-brain barrier platform and the next-generation neurodegeneration programs enabled by the technology.
● MIMI – Will begin trading under its new corporate name, Axonex AI Group Limited, and new Nasdaq ticker AXNX at market open on October 13, 2026. The rebranding reflects the company’s strategic expansion into AI and robotics.
● CTSO – Will present CytoSorb data in critical-care applications at the European Society of Intensive Care Medicine Annual Congress in Lisbon, which runs through October 14, 2026. The company’s preceding EACTS cardiac-surgery presentations concluded October 10.
● IRD – Will present two analyses at Retina in Rio on October 14, 2026. One presentation will cover structure-function correlations from the Phase 1/2 BIRD-1 study of OPGx-BEST1 gene therapy, while the second will address near-normalization of cone sensitivity following gene augmentation in children with LCA5.
● GCTK – Expects Qare, its comparative-health platform for evaluating treatment experiences across patients taking drugs within the same therapeutic class, to become publicly available on October 14, 2026. The initial launch will focus on GLP-1 therapies.
● TSHA – Will present multiple encore analyses supporting the TSHA-102 Rett syndrome gene-therapy program at the 55th Child Neurology Society Annual Meeting in Montréal from October 14–17, 2026.
● FFR – Alongside Faraday Future, will host a launch event on October 14, 2026 focused on new EAI Brain and Skills products, EAI Devices for the education market, and the unveiling of the Physical AI Spark Program and related products.
● FFAI – Alongside its robotics business, will host an October 14, 2026 launch event for new EAI Brain and Skills products, EAI education devices, and the Physical AI Spark Program as part of its broader Four-Core Full-Stack AI Robotics Education Ecosystem strategy.
● MODD – CEO Jeb Besser will present at the Webull Emerging & Innovative Companies Webinar on October 14, 2026 at 1:00 p.m. ET.
● CSAI – CEO James McCormick and CFO Greg Smitherman will present at the Webull Emerging & Innovative Companies Webinar on October 14, 2026 at 1:00 p.m. ET.
● AKBA – CEO John Butler, Chief R&D and Medical Officer Steven Burke, and CFO/Chief Business Officer Erik Ostrowski will participate in one-on-one investor meetings at the Virtual U.S. Bancorp | BTIG Kidney Health Forum on October 14, 2026.
● NYXH – Will present the complete 12-month dataset from the ACCCESS U.S. pivotal study of the Genio system at the International Surgical Sleep Society annual meeting in Los Angeles from October 15–16, 2026. The study previously met both co-primary efficacy endpoints and its safety endpoints in patients with complete concentric collapse of the soft palate.
● PDSB – Will host a virtual KOL event on October 15, 2026 at 8:00 a.m. ET focused on clinical outcomes from the PDS0301 Phase 2 trials in advanced liver-associated cancers, particularly the metastatic colorectal cancer cohort. The discussion will address MSS/pMMR colorectal liver metastases and the potential role of the IL-12 immunocytokine in a population where immunotherapy has historically had limited effectiveness.
● BURU – Is targeting October 15, 2026 for the notarial meeting related to its proposed acquisition of a 70% controlling interest in Tekne through NUBURU Defense Italy. The transaction has received Italian Golden Power authorization but remains subject to final corporate approvals, notarial formalities, documentation, and compliance with authorization conditions.
● APRE – CEO Oren Gilad will participate in the Regional Biotechnology Conference in Doylestown, Pennsylvania, on October 15, 2026, following participation earlier in the week at the Maxim Growth Summit.
● VRCA – Will present posters at the 2026 PeDRA Annual Conference in Alexandria, Virginia, from October 15–17, 2026, including a new analysis of Phase 3 YCANTH data and an encore presentation of Phase 2 VP-315 results.
● PULM – Will hold a special meeting of stockholders on October 16, 2026 at 8:30 a.m. ET to vote on its proposed merger with Eos SENOLYTIX and related transactions. At closing, approximately 54.36 million common shares are expected to be issued to Eos stockholders and financing investors, with approximately 20.89 million additional securities underlying warrants, options, and RSUs for potential total issuance of about 75.25 million shares. Existing securityholders are estimated to own roughly 6% of the combined company on a fully diluted basis excluding CEO RSUs, versus approximately 94% for Eos-related holders. Shareholders will also vote on a reverse split ranging from 1-for-2 to 1-for-10, an increase in authorized common shares from 200 million to 250 million, and a new equity incentive plan. If completed, the company is expected to be renamed Eos SENOLYTIX Inc. and trade under MTXL.
● SLE – Will hold its 2026 Annual Meeting on October 16, 2026, with shareholders asked to approve the transaction that would result in Metaplanet becoming the company’s controlling shareholder. Subject to approval and other closing conditions, the Nasdaq-listed company would be renamed Superplanet, Inc. while remaining publicly traded in the U.S.
● KITT – Will participate as a partner and presenter at Defence iQ’s Seabed Security and Uncrewed Naval Systems conferences in Troia, Portugal, on October 13–14, 2026. The events focus on maritime security, seabed infrastructure protection, autonomous naval systems, and uncrewed maritime technologies, providing a relevant showcase for its subsea robotics and autonomy software.
--
Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.
Disclaimer: Penny stock trading involves substantial risk, so always research every alert before trading, consult with a licensed professional before trading, only invest what you can afford to lose, and always trade with caution. Readers should independently investigate and fully understand all risks before investing. Results listed are NOT typical and individual results may and most likely will vary. Bigtimepennystocks.com and its staff are NOT licensed investment advisors or broker/dealers of any kind.Alerts are not a solicitation or recommendation to buy/sell/hold securities but merely investment ideas that should NEVER serve as the basis of your trading decisions. Bigtimepennystocks.com and its newsletter are for entertainment purposes only. This website and its reports are for general information purposes as we are engaged in the business of marketing and advertising companies for monetary compensation. Any investment decision should be discussed with a financial adviser before taking place. Please invest carefully and read investment information available at the website of the SEC at http://www.sec.gov.
Subscribe to our Free Newsletter
Copyright © 2023 BigTimePennyStocks.com - All Rights Reserved.